✦ LIBER ✦

Progress or backsliding on HIV and illicit drugs in 2008?

✍ Scribed by Joanne Csete; Daniel Wolfe

Book ID: 117303011
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 48 KB
Volume: 371
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(08)60777-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective one-year bone loss in treatm

Prospective one-year bone loss in treatment-naïve HIV+ men and women on single or multiple drug HIV therapies

✍ K. Briot; S. Kolta; P. Flandre; F. Boué; P. Ngo Van; I. Cohen-Codar; M. Norton; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 463 KB

The evolution of HIV-1 subtypes and dise

The evolution of HIV-1 subtypes and disease progression among adults on anti-retroviral drugs in Northern Tanzania

✍ E Shao, B Nyombi, J Sabuni 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 75 KB

Genetic variability and drug resistance

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon

✍ L Agyingi, D Barengolts, L Mayr, T Kinge, M MBida, P Nyambi 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 76 KB

Commentary on Thorne et al. (2012): HIV

Commentary on Thorne et al. (2012): HIV prevention and treatment in female injection drug users – a work in progress

✍ RONALD C. HERSHOW 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Prediction of HIV Drug Resistance Based

Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon

✍ Boulle, C.; Kouanfack, C.; Laborde-Balen, G.; Aghokeng, A. F.; Boyer, S.; Carrie 📂 Article 📅 2013 🏛 University of Chicago Press 🌐 English ⚖ 91 KB

Similar effects of disease-modifying ant

✍ Niels Graudal; Gesche Jürgens 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## Objective To define the differences in effects on joint destruction in rheumatoid arthritis (RA) patients between therapy with single and combination disease‐modifying antirheumatic drugs (DMARDs), glucocorticoids, and biologic agents. ## Methods Randomized controlled trials in RA